Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 323 | |
-3.17% | 102B | |
+1.65% | 96.29B | |
+2.13% | 22.18B | |
-15.86% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.77% | 16.36B | |
+5.33% | 13.97B | |
+32.59% | 12.17B |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Nabriva Therapeutics Signs Extended Deal With Merck to Promote, Distribute Sivextro Through December 2026